Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy |
| |
| Authors: | Onorina Berardicurti Piero Ruscitti Viktoriya Pavlych Alessandro Conforti Roberto Giacomelli Paola Cipriani |
| |
| Affiliation: | 1. Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila , L’Aquila, Italy onorina.berardicurti@graduate.univaq.it berardicurtio@libero.it!["ORCID]("//:0" "\"ORCID") https://orcid.org/0000-0002-2808-1581;3. Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila , L’Aquila, Italy;4. Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila , L’Aquila, Italy https://orcid.org/0000-0003-0670-9638 |
| |
| Abstract: | ABSTRACT Introduction Glucocorticoids (GCs) are key actors in RA management, despite the increasing number of available drugs. In fact, due to their efficacy and safety, the combination therapy between GCs and conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) is still recommended in the early phase of RA treatment, because improving the long-term results. |
| |
| Keywords: | Adverse events corticosteroids drug efficacy glucocorticoids rheumatoid arthritis therapies |
|
|
!["ORCID]({"type":"image","src":"/templates/jsp/images/orcid.png"} "\"ORCID")
https://orcid.org/0000-0002-2808-1581;3. Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila , L’Aquila, Italy;4. Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila , L’Aquila, Italy